Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for OCGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.74 9.64 %
R2 1.69 6.28 %
R1 1.66 4.20 %
Current price: 1.59
Support S1 1.55 -2.52 %
S2 1.52 -4.60 %
S3 1.46 -7.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.83 15.09 %
R2 1.73 8.81 %
R1 1.64 3.14 %
Current price 1.59
Support S1 1.34 -15.72%
S2 1.32 -16.98%
S3 1.24 -22.01%

OCGN Predictions History

3 years ago
iHustle84 predicted that OCGN for 2020-07-22 is going $0.200 (-36.45%)

3 years ago
sander7100 yo bro predicted that OCGN for 2020-07-09 is going $0.213 (-3.18%)

3 years ago
JS predicted that OCGN for 2020-07-09 is going $0.217 (-1.36%)

3 years ago
iHustle84 predicted that OCGN for 2020-07-09 is going $0.190 (-13.64%)

3 years ago
Mark167401 predicted that OCGN for 2020-07-09 is going

Rank:

3 years ago
JS predicted that OCGN for 2020-06-18 is going $0.235 (-3.96%)

3 years ago
JamarrJames predicted that OCGN for 2020-06-18 is going

Rank:

3 years ago
Awes predicted that OCGN for 2020-06-18 is going $0.400 (59.36%)

Rank:

3 years ago
friend s predicted that OCGN for 2020-06-18 is going

Rank:

3 years ago
Sheik Louison predicted that OCGN for 2020-06-18 is going $0.273 (8.69%)

Rank:
Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT